Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

The impact of diabetic peripheral neuropathy on pinch proprioception.

Yahya A, Kluding P, Pasnoor M, Wick J, Liu W, Dos Santos M.

Exp Brain Res. 2019 Oct 4. doi: 10.1007/s00221-019-05663-3. [Epub ahead of print]

PMID:
31586215
2.

Immunosuppressive and immunomodulatory therapies for neuromuscular diseases. Part II: New and novel agents.

Farmakidis C, Dimachkie MM, Pasnoor M, Barohn RJ.

Muscle Nerve. 2019 Sep 18. doi: 10.1002/mus.26711. [Epub ahead of print] Review.

PMID:
31531874
3.

Immunosuppressive and immunomodulatory therapies for neuromuscular diseases. Part I: Traditional agents.

Farmakidis C, Dimachkie MM, Pasnoor M, Barohn RJ.

Muscle Nerve. 2019 Sep 11. doi: 10.1002/mus.26708. [Epub ahead of print] Review.

PMID:
31509257
4.

Investigation of the psychometric properties of the inclusion body myositis functional rating scale with rasch analysis.

Ramdharry G, Morrow J, Hudgens S, Skorupinska I, Gwathmey K, Currence M, Herbelin L, Jawdat O, Pasnoor M, Mcvey A, Barohn RJ, Burns TM, Dimachkie MM, Amato AA, Hanna MG, Machado PM.

Muscle Nerve. 2019 Aug;60(2):161-168. doi: 10.1002/mus.26521. Epub 2019 Jun 7. Erratum in: Muscle Nerve. 2019 Oct;60(4):484.

PMID:
31107564
5.

When should you order genetic testing for patients with cryptogenic neuropathy? Let the data do the talking.

Pasnoor M, Gordon Smith A.

Muscle Nerve. 2019 Mar;59(3):280-282. doi: 10.1002/mus.26409. Epub 2019 Jan 23. No abstract available.

PMID:
30615209
6.

Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravis.

Clifford KM, Hobson-Webb LD, Benatar M, Burns TM, Barnett C, Silvestri NJ, Howard JF Jr, Visser A, Crum BA, Nowak R, Beekman R, Kumar A, Ruzhansky K, Chen IA, Pulley MT, Laboy SM, Fellman MA, Howard DB, Kolb NA, Greene SM, Pasnoor M, Dimachkie MM, Barohn RJ, Hehir MK.

Muscle Nerve. 2019 Apr;59(4):404-410. doi: 10.1002/mus.26404. Epub 2019 Jan 14.

PMID:
30575980
7.

Satisfactory Response With Achieving Maintenance Low-Dose Prednisone in Generalized Myasthenia Gravis.

Abuzinadah AR, Jabari D, Jawdat O, Pasnoor M, Glenn M, Herbelin L, McVey AL, Barohn RJ, Dimachkie MM.

J Clin Neuromuscul Dis. 2018 Dec;20(2):49-59. doi: 10.1097/CND.0000000000000219.

PMID:
30439750
8.

Toxic myopathies.

Pasnoor M, Barohn RJ, Dimachkie MM.

Curr Opin Neurol. 2018 Oct;31(5):575-582. doi: 10.1097/WCO.0000000000000606. Review.

PMID:
30080718
9.

Congenital Myasthenic Syndromes: a Clinical and Treatment Approach.

Farmakidis C, Pasnoor M, Barohn RJ, Dimachkie MM.

Curr Treat Options Neurol. 2018 Jul 21;20(9):36. doi: 10.1007/s11940-018-0520-7. Review.

PMID:
30032336
10.

Treatment of Myasthenia Gravis.

Farmakidis C, Pasnoor M, Dimachkie MM, Barohn RJ.

Neurol Clin. 2018 May;36(2):311-337. doi: 10.1016/j.ncl.2018.01.011. Review.

11.

Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.

Rivner MH, Pasnoor M, Dimachkie MM, Barohn RJ, Mei L.

Neurol Clin. 2018 May;36(2):293-310. doi: 10.1016/j.ncl.2018.01.004. Review.

12.

Diagnosis of Myasthenia Gravis.

Pasnoor M, Dimachkie MM, Farmakidis C, Barohn RJ.

Neurol Clin. 2018 May;36(2):261-274. doi: 10.1016/j.ncl.2018.01.010. Review.

PMID:
29655449
13.

An instrumented timed up and go in facioscapulohumeral muscular dystrophy.

Huisinga J, Bruetsch A, Mccalley A, Currence M, Herbelin L, Jawdat O, Pasnoor M, Dimachkie M, Barohn R, Statland J.

Muscle Nerve. 2018 Mar;57(3):503-506. doi: 10.1002/mus.25955. Epub 2017 Oct 6.

14.

Less is More in Diabetic Neuropathy Diagnosis: Comparison of Quantitative Sudomotor Axon Reflex and Skin Biopsy.

Abuzinadah AR, Kluding P, Wright D, DʼSilva L, Ryals J, Hendry B, Jawdat O, Herbelin L, McVey AL, Barohn RJ, Dimachkie MM, Pasnoor M.

J Clin Neuromuscul Dis. 2017 Sep;19(1):5-11. doi: 10.1097/CND.0000000000000150.

PMID:
28827483
15.

Rituximab as treatment for anti-MuSK myasthenia gravis: Multicenter blinded prospective review.

Hehir MK, Hobson-Webb LD, Benatar M, Barnett C, Silvestri NJ, Howard JF Jr, Howard D, Visser A, Crum BA, Nowak R, Beekman R, Kumar A, Ruzhansky K, Chen IA, Pulley MT, LaBoy SM, Fellman MA, Greene SM, Pasnoor M, Burns TM.

Neurology. 2017 Sep 5;89(10):1069-1077. doi: 10.1212/WNL.0000000000004341. Epub 2017 Aug 11.

PMID:
28801338
16.

Author response: A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis.

Pasnoor M.

Neurology. 2017 Jan 24;88(4):417-418. doi: 10.1212/WNL.0000000000003549. No abstract available.

PMID:
28115604
17.

A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization.

Brown AR, Gajewski BJ, Aaronson LS, Mudaranthakam DP, Hunt SL, Berry SM, Quintana M, Pasnoor M, Dimachkie MM, Jawdat O, Herbelin L, Barohn RJ.

Trials. 2016 Aug 31;17(1):428. doi: 10.1186/s13063-016-1544-5.

18.

Activity for Diabetic Polyneuropathy (ADAPT): Study Design and Protocol for a 2-Site Randomized Controlled Trial.

Kluding PM, Singleton JR, Pasnoor M, Dimachkie MM, Barohn RJ, Smith AG, Marcus RL.

Phys Ther. 2017 Jan 1;97(1):20-31. doi: 10.2522/ptj.20160200.

19.

A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis.

Pasnoor M, He J, Herbelin L, Burns TM, Nations S, Bril V, Wang AK, Elsheikh BH, Kissel JT, Saperstein D, Shaibani JA, Jackson C, Swenson A, Howard JF Jr, Goyal N, David W, Wicklund M, Pulley M, Becker M, Mozaffar T, Benatar M, Pazcuzzi R, Simpson E, Rosenfeld J, Dimachkie MM, Statland JM, Barohn RJ; Methotrexate in MG Investigators of the Muscle Study Group.

Neurology. 2016 Jul 5;87(1):57-64. doi: 10.1212/WNL.0000000000002795. Epub 2016 Jun 15.

20.

Targeting protein homeostasis in sporadic inclusion body myositis.

Ahmed M, Machado PM, Miller A, Spicer C, Herbelin L, He J, Noel J, Wang Y, McVey AL, Pasnoor M, Gallagher P, Statland J, Lu CH, Kalmar B, Brady S, Sethi H, Samandouras G, Parton M, Holton JL, Weston A, Collinson L, Taylor JP, Schiavo G, Hanna MG, Barohn RJ, Dimachkie MM, Greensmith L.

Sci Transl Med. 2016 Mar 23;8(331):331ra41. doi: 10.1126/scitranslmed.aad4583.

21.

Aerobic exercise improves measures of vascular health in diabetic peripheral neuropathy.

Billinger SA, Sisante JV, Alqahtani AS, Pasnoor M, Kluding PM.

Int J Neurosci. 2017 Jan;127(1):80-85. Epub 2016 Feb 16.

22.

Disease course and therapeutic approach in dermatomyositis: A four-center retrospective study of 100 patients.

Johnson NE, Arnold WD, Hebert D, Gwathmey K, Dimachkie MM, Barohn RJ, McVey AL, Pasnoor M, Amato AA, McDermott MP, Kissel J, Heatwole CR.

Neuromuscul Disord. 2015 Aug;25(8):625-31. doi: 10.1016/j.nmd.2015.04.013. Epub 2015 May 7.

23.

Pilot Study of Exercise Therapy on Painful Diabetic Peripheral Neuropathy.

Yoo M, D'Silva LJ, Martin K, Sharma NK, Pasnoor M, LeMaster JW, Kluding PM.

Pain Med. 2015 Aug;16(8):1482-9. doi: 10.1111/pme.12743. Epub 2015 Mar 20.

24.

A genome-wide association study of myasthenia gravis.

Renton AE, Pliner HA, Provenzano C, Evoli A, Ricciardi R, Nalls MA, Marangi G, Abramzon Y, Arepalli S, Chong S, Hernandez DG, Johnson JO, Bartoccioni E, Scuderi F, Maestri M, Gibbs JR, Errichiello E, Chiò A, Restagno G, Sabatelli M, Macek M, Scholz SW, Corse A, Chaudhry V, Benatar M, Barohn RJ, McVey A, Pasnoor M, Dimachkie MM, Rowin J, Kissel J, Freimer M, Kaminski HJ, Sanders DB, Lipscomb B, Massey JM, Chopra M, Howard JF Jr, Koopman WJ, Nicolle MW, Pascuzzi RM, Pestronk A, Wulf C, Florence J, Blackmore D, Soloway A, Siddiqi Z, Muppidi S, Wolfe G, Richman D, Mezei MM, Jiwa T, Oger J, Drachman DB, Traynor BJ.

JAMA Neurol. 2015 Apr;72(4):396-404. doi: 10.1001/jamaneurol.2014.4103.

25.

Building efficient comparative effectiveness trials through adaptive designs, utility functions, and accrual rate optimization: finding the sweet spot.

Gajewski BJ, Berry SM, Quintana M, Pasnoor M, Dimachkie M, Herbelin L, Barohn R.

Stat Med. 2015 Mar 30;34(7):1134-49. doi: 10.1002/sim.6403. Epub 2015 Jan 7.

26.

Safety of aerobic exercise in people with diabetic peripheral neuropathy: single-group clinical trial.

Kluding PM, Pasnoor M, Singh R, D'Silva LJ, Yoo M, Billinger SA, LeMaster JW, Dimachkie MM, Herbelin L, Wright DE.

Phys Ther. 2015 Feb;95(2):223-34. doi: 10.2522/ptj.20140108. Epub 2014 Oct 2.

27.

Pompe disease: literature review and case series.

Dasouki M, Jawdat O, Almadhoun O, Pasnoor M, McVey AL, Abuzinadah A, Herbelin L, Barohn RJ, Dimachkie MM.

Neurol Clin. 2014 Aug;32(3):751-76, ix. doi: 10.1016/j.ncl.2014.04.010. Review.

28.

Toxic myopathies.

Pasnoor M, Barohn RJ, Dimachkie MM.

Neurol Clin. 2014 Aug;32(3):647-70, viii. doi: 10.1016/j.ncl.2014.04.009. Review.

29.

Leg amyotrophic diplegia: prevalence and pattern of weakness at US neuromuscular centers.

Dimachkie MM, Muzyka IM, Katz JS, Jackson C, Wang Y, McVey AL, Dick A, Pasnoor M, Mozaffar MT, Xiao-Song Z, Kissel JT, Ensrud E, Rosenfeld J, Barohn RJ.

J Clin Neuromuscul Dis. 2013 Sep;15(1):7-12. doi: 10.1097/CND.0b013e31829e22d1.

30.

Painful Diabetic Peripheral Neuropathy: Presentations, Mechanisms, and Exercise Therapy.

Yoo M, Sharma N, Pasnoor M, Kluding PM.

J Diabetes Metab. 2013 Jun 30;Suppl 10. pii: 005.

31.

Cryptogenic sensory polyneuropathy.

Pasnoor M, Dimachkie MM, Barohn RJ.

Neurol Clin. 2013 May;31(2):463-76. doi: 10.1016/j.ncl.2013.01.008. Epub 2013 Mar 13. Review.

32.

Diabetic neuropathy part 2: proximal and asymmetric phenotypes.

Pasnoor M, Dimachkie MM, Barohn RJ.

Neurol Clin. 2013 May;31(2):447-62. doi: 10.1016/j.ncl.2013.02.003. Epub 2013 Mar 15. Review.

33.

Diabetic neuropathy part 1: overview and symmetric phenotypes.

Pasnoor M, Dimachkie MM, Kluding P, Barohn RJ.

Neurol Clin. 2013 May;31(2):425-45. doi: 10.1016/j.ncl.2013.02.004. Epub 2013 Mar 15. Review.

34.

North America and South America (NA-SA) neuropathy project.

Pasnoor M, Nascimento OJ, Trivedi J, Wolfe GI, Nations S, Herbelin L, de Freitas MG, Quintanilha G, Khan S, Dimachkie M, Barohn R.

Int J Neurosci. 2013 Aug;123(8):563-7. doi: 10.3109/00207454.2013.782026. Epub 2013 Apr 17.

PMID:
23461611
35.

Phase II trial of methotrexate in myasthenia gravis.

Pasnoor M, He J, Herbelin L, Dimachkie M, Barohn RJ; Muscle Study Group.

Ann N Y Acad Sci. 2012 Dec;1275:23-8. doi: 10.1111/j.1749-6632.2012.06804.x.

36.

Postprocedural neuropathy after atrial fibrillation ablation.

Reddy YM, Singh D, Chikkam V, Bommana S, Atkins D, Verma A, Swarup V, Khaykin Y, Nalamachu S, Pasnoor M, Lakkireddy D.

J Interv Card Electrophysiol. 2013 Apr;36(3):279-85. doi: 10.1007/s10840-012-9724-z. Epub 2012 Dec 9.

PMID:
23224798
37.

Benefit of Qigong exercise in patients with fibromyalgia: a pilot study.

Liu W, Zahner L, Cornell M, Le T, Ratner J, Wang Y, Pasnoor M, Dimachkie M, Barohn R.

Int J Neurosci. 2012 Nov;122(11):657-64. doi: 10.3109/00207454.2012.707713. Epub 2012 Aug 3.

PMID:
22784212
38.

The effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy.

Kluding PM, Pasnoor M, Singh R, Jernigan S, Farmer K, Rucker J, Sharma NK, Wright DE.

J Diabetes Complications. 2012 Sep-Oct;26(5):424-9. doi: 10.1016/j.jdiacomp.2012.05.007. Epub 2012 Jun 18.

39.

Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response.

Mittal MK, Barohn RJ, Pasnoor M, McVey A, Herbelin L, Whittaker T, Dimachkie M.

J Clin Neuromuscul Dis. 2011 Sep;13(1):46-52. doi: 10.1097/CND.0b013e31821c5634.

PMID:
22361625
40.

Retrospective chart review of duloxetine and pregabalin in the treatment of painful neuropathy.

Mittal M, Pasnoor M, Mummaneni RB, Khan S, McVey A, Saperstein D, Herbelin L, Ridings L, Wang Y, Dimachkie MM, Barohn RJ.

Int J Neurosci. 2011 Sep;121(9):521-7. doi: 10.3109/00207454.2011.582238. Epub 2011 Jun 15.

41.

Autonomic nerve function in adult patients with cyclic vomiting syndrome.

Hejazi RA, Lavenbarg TH, Pasnoor M, Dimachkie M, Foran P, Herbelin L, McCallum RW.

Neurogastroenterol Motil. 2011 May;23(5):439-43. doi: 10.1111/j.1365-2982.2011.01679.x. Epub 2011 Feb 16.

PMID:
21323793
42.

Creutzfeldt-Jakob disease presenting as bulbar palsy.

Mittal M, Hammond N, Husmann K, Lele A, Pasnoor M.

Muscle Nerve. 2010 Nov;42(5):833-5. doi: 10.1002/mus.21849.

PMID:
20976786
43.

Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience.

Pasnoor M, Wolfe GI, Nations S, Trivedi J, Barohn RJ, Herbelin L, McVey A, Dimachkie M, Kissel J, Walsh R, Amato A, Mozaffar T, Hungs M, Chui L, Goldstein J, Novella S, Burns T, Phillips L, Claussen G, Young A, Bertorini T, Oh S.

Muscle Nerve. 2010 Mar;41(3):370-4. doi: 10.1002/mus.21533.

PMID:
19882635
44.

Chordae tendinae tumor as the cause of cardioembolic stroke.

Dafer RM, Pasnoor M, Gorton ME, Gollub S.

J Stroke Cerebrovasc Dis. 2006 Mar-Apr;15(2):72-3.

PMID:
17904053
45.

Multiparametric iterative self-organizing MR imaging data analysis technique for assessment of tissue viability in acute cerebral ischemia.

Mitsias PD, Ewing JR, Lu M, Khalighi MM, Pasnoor M, Ebadian HB, Zhao Q, Santhakumar S, Jacobs MA, Papamitsakis N, Soltanian-Zadeh H, Hearshen D, Patel SC, Chopp M.

AJNR Am J Neuroradiol. 2004 Oct;25(9):1499-508.

46.

MRI tissue characterization of experimental cerebral ischemia in rat.

Soltanian-Zadeh H, Pasnoor M, Hammoud R, Jacobs MA, Patel SC, Mitsias PD, Knight RA, Zheng ZG, Lu M, Chopp M.

J Magn Reson Imaging. 2003 Apr;17(4):398-409.

PMID:
12655578
47.

Multiparametric MRI ISODATA ischemic lesion analysis: correlation with the clinical neurological deficit and single-parameter MRI techniques.

Mitsias PD, Jacobs MA, Hammoud R, Pasnoor M, Santhakumar S, Papamitsakis NI, Soltanian-Zadeh H, Lu M, Chopp M, Patel SC.

Stroke. 2002 Dec;33(12):2839-44.

PMID:
12468779

Supplemental Content

Loading ...
Support Center